Delivery Order SPE2DB22D6029-SPE2DB24FLSWP

Award Date 8/27/24
Potential Completion Date 8/28/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,120.10 firm-fixed-price contract is for the delivery of 4,568,193,879 units of the medication methylergonovine 0.2 mg tablets. The contract has a performance period through May 12, 2025 and was awarded on May 9, 2025. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $8,015.37, is for the delivery of 4,558,459,996 tablets of the medication Methylergonovine 0.2 mg. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of September 15, 2022. This award is not associated with a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,563,239,903 units of the drug Methylergonovine 0.2 mg Tablet. The contract has a ceiling value of $2,226.26 and a period of performance through January 5, 2024. It is a Firm Fixed Price Delivery Order contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,563,032,696 units of the pharmaceutical drug Methylergonovine 0.2 mg Tablet in 28-count packages. The award has a ceiling value of $21,472.44 and a completion date of December 8, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract is not...
This federal contract award, with a ceiling value of $3,757.27, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560732288 - Methylergonovine 0.2 mg Tablet 12s, with a completion date of April 27, 2023. The award is a Firm Fixed Price Delivery Order contract, and there is no set-aside designation mentioned. AmerisourceBergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,116.44 firm fixed-price contract is for the delivery of 4557734719 methylergonovine 0.2 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a broad range of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 4565601890 Methylergonovine 0.2 mg Tablets in quantities of 12 per package. The contract has a Firm Fixed Price pricing type and a ceiling value of $5,661.76. The period of performance extends to August 28, 2024. This contract award is not associated with a set-aside designation. AmerisourceBergen, through its...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,410.20, is for the delivery of 4568112775 methylergonovine 0.2 mg tablets. The contract has a period of performance through May 5, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 4,563,501,441 units of the pharmaceutical product Methylergonovine 0.2 mg Tablet 28s. The $2,829.93 contract has a completion date of February 1, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,498.80 firm fixed-price delivery order is for the supply of 4,567,972,776 units of the medication methylergonovine 0.2 mg tablet in 20-count units. The contract has an ultimate completion date of April 21, 2025 and was awarded on April 19, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB24FLSWP
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is for the delivery of 4,565,589,107 units of the medication Methylergonovine 0.2 MG Tablet in 28-count blister packs, with a ceiling value of $2,243.58. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 28, 2024. This award is not associated with a set-aside program. AmerisourceBergen, through its extensive supply chain network, has been a significant provider of essential medical commodities to various federal agencies and healthcare programs, including military treatment facilities and veterans' hospitals.

Generated 11/26/24, 9:02 AM